Literature DB >> 3753076

Prevention of reperfusion injury of the ischemic spinal cord: use of recombinant superoxide dismutase.

K H Lim, M Connolly, D Rose, F Siegman, I Jacobowitz, A Acinapura, J N Cunningham.   

Abstract

We investigated the effect of recombinant superoxide dismutase, an oxygen free radical scavenger, on the prevention of reperfusion injury of the ischemic spinal cord. Somatosensory evoked potentials (SEPs) were obtained in 23 dogs. Spinal cord ischemia was produced by cross-clamping the descending thoracic aorta just distal to the origin of the left subclavian artery through a left thoracotomy. Mean proximal aortic blood pressure was maintained between 90 and 100 mm Hg by partial exsanguination. Serial SEPs were obtained at 60-second intervals until the SEP disappeared. Aortic cross-clamping was continued for 10 additional minutes after the disappearance of the SEP. In Group 1 (N = 8), no medication was given when the aortic cross-clamp was removed. In Group 2 (N = 8), a bolus of 25,000 units of superoxide dismutase was injected into the proximal aorta prior to removal of the aortic cross-clamp, and was followed by 5,000 units per minute for 10 minutes after release of the cross-clamp. In Group 3 (N = 7), 50,000 units of superoxide dismutase was administered as a bolus prior to removal of the aortic cross-clamp, followed by an additional 10,000 units per minute for 10 minutes as in Group 2. The postoperative neurological status was assessed by Tarlov's criteria. There was no significant difference in aortic cross-clamp time among the three groups. Paraplegia developed in 4 animals in Group 1; the remaining 4 dogs had paraparesis. In Group 2, paraparesis developed in 2 of 8 dogs; the other 6 had no neurological injury. All the animals in Group 3 had complete recovery.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3753076     DOI: 10.1016/s0003-4975(10)62735-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  Cerebral Monitoring in the Operating Room and the Intensive Care Unit: An introductory for the clinician and a guide for the novice wanting to open a window to the brain. Part III: Spinal cord evoked potentials.

Authors:  Enno Freye
Journal:  J Clin Monit Comput       Date:  2005-04       Impact factor: 2.502

2.  Effects of a cantaloupe melon extract/wheat gliadin biopolymer during aortic cross-clamping.

Authors:  Jochen Kick; Balázs Hauser; Hendrik Bracht; Maura Albicini; Sükrü Oter; Florian Simon; Ulrich Ehrmann; Catherine Garrel; Jörn Sträter; Uwe B Brückner; Xavier M Leverve; Hubert Schelzig; Günter Speit; Peter Radermacher; Claus-Martin Muth
Journal:  Intensive Care Med       Date:  2007-01-20       Impact factor: 17.440

3.  Phospholipid composition in spinal cord regions after ischemia/reperfusion.

Authors:  N Lukácová; P Jalc; J Marsala
Journal:  Neurochem Res       Date:  1998-08       Impact factor: 3.996

4.  Spinal evoked potential in patients undergoing thoracoabdominal aortic reconstruction: a prognostic indicator of postoperative motor deficit.

Authors:  K Grabitz; E Freye; K Stühmeier; W Sandmann
Journal:  J Clin Monit       Date:  1993-07

5.  The effect of adrenergic β(2) receptor agonist on paraplegia following clamping of abdominal aorta.

Authors:  Bok Y Lee; Noori Al-Waili; Glenn Butler
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

6.  MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway.

Authors:  Xiao-Qian Li; Huang-Wei Lv; Zhi-Lin Wang; Wen-Fei Tan; Bo Fang; Hong Ma
Journal:  J Neuroinflammation       Date:  2015-02-07       Impact factor: 8.322

7.  Inhibition of sevoflurane postconditioning against cerebral ischemia reperfusion-induced oxidative injury in rats.

Authors:  Yan Zhang; Fu-Geng Zhang; Chun Meng; Shou-Yuan Tian; Ya-Xin Wang; Wei Zhao; Jun Chen; Xiu-Shan Zhang; Yu Liang; Shi-Dong Zhang; Yan-Jie Xing
Journal:  Molecules       Date:  2011-12-30       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.